Last week GlaxoSmithKline (GSK), one of the world’s leading research-based pharmaceutical and healthcare companies and the PATH Malaria Vaccine Intiative (MVI), announced that the world may be closer to a malaria vaccine than once thought.  Working together, MVI and GSK announced results from a large scale trail in Africa testing the RTS,S vaccine which demonstrated…

Read More